Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Cash from Financing Activities: 2023-2024

Historic Cash from Financing Activities for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $418.9 million.

  • Upstream Bio's Cash from Financing Activities rose 146.31% to $760,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $272.0 million, marking a year-over-year increase of 83.61%. This contributed to the annual value of $418.9 million for FY2024, which is 223.36% up from last year.
  • Latest data reveals that Upstream Bio reported Cash from Financing Activities of $418.9 million as of FY2024, which was up 223.36% from $129.6 million recorded in FY2023.
  • Upstream Bio's 5-year Cash from Financing Activities high stood at $418.9 million for FY2024, and its period low was $129.6 million during FY2023.
  • Its 2-year average for Cash from Financing Activities is $274.2 million, with a median of $274.2 million in 2023.
  • Data for Upstream Bio's Cash from Financing Activities shows a peak YoY skyrocketed of 223.36% (in 2024) over the last 5 years.
  • Upstream Bio's Cash from Financing Activities (Yearly) stood at $129.6 million in 2023, then spiked by 223.36% to $418.9 million in 2024.